NASDAQ IMMY

All press releases contained in this web site were, to the best of Imprimis’s knowledge, current and accurate only as of their respective dates. However, the passage of time may have rendered the information contained therein stale. Imprimis does not review past press releases to determine whether they remain accurate, and information contained in such press releases may have been superseded or otherwise changed. Imprimis disclaims any responsibility to update or amend any such outdated information.

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.